Valuation : Embecta Corp.

Market Cap 280M 241M 228M 207M 388M 26.74B 390M 2.71B 1.04B 13.6B 1.05B 1.03B 42.99B P/E 2026 *
4.17x
P/E 2027 * 3.58x
Enterprise Value 280M 241M 228M 207M 388M 26.74B 390M 2.71B 1.04B 13.6B 1.05B 1.03B 42.99B EV / Sales 2026 *
0.27x
EV / Sales 2027 * 0.26x
Free-Float
97.99%
Yield 2026 *
5.1%
Yield 2027 * 0.82%
1 day+1.02%
1 week-14.83%
Current month-3.89%
1 month+4.00%
3 months+59.35%
6 months-43.93%
Current year-58.42%
1 week 4.87
Extreme 4.87
5.76
1 month 4.8
Extreme 4.8
5.91
Current year 2.77
Extreme 2.77
13.44
1 year 2.77
Extreme 2.77
15.55
3 years 2.77
Extreme 2.77
21.48
5 years 0
Extreme 0
49
10 years 0
Extreme 0
49
Manager TitleAgeSince
Chief Executive Officer 58 2022-03-21
Director of Finance/CFO 53 2022-03-21
Investor Relations Contact - 2022-05-31
Director TitleAgeSince
Chairman 58 2026-02-10
Director/Board Member 60 2022-03-19
Director/Board Member 58 2022-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Sell

Director

-6,293 0.0111%
8/12/26 Buy

General Counsel

20,000 0.0337%
8/12/26 Buy

Chief Financial Officer

20,000 0.0337%
Change 5-day change 1-year change 3-year change Capi.($)
+1.02%-14.83%-67.09%-70.44% 280M
-1.36%-5.89%-23.76%-0.44% 176B
-0.72%-3.41%-3.26%+12.32% 116B
+0.19%-2.83%+6.30%+80.17% 61.36B
-1.92%-6.01%+7.05%+38.44% 49.42B
+0.81%-3.73%-4.81%-32.56% 48.44B
-1.75%-5.54%+8.93%-20.82% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.08% 24.37B
+0.49%-7.65%-13.30%+3.79% 21.57B
Average -0.22%-6.06%-5.93%-0.18% 55.81B
Weighted average by Cap. -0.69%-4.90%-6.05%+10.79%

Financials

2026 *2027 *
Net sales 1.02B 883M 836M 758M 1.42B 97.88B 1.43B 9.93B 3.82B 49.79B 3.85B 3.76B 157B 1.08B 932M 883M 800M 1.5B 103B 1.51B 10.48B 4.03B 52.58B 4.06B 3.97B 166B
Net income 69.3M 59.71M 56.54M 51.24M 96.14M 6.62B 96.62M 671M 258M 3.37B 260M 255M 10.64B 76.83M 66.2M 62.68M 56.82M 107M 7.34B 107M 744M 286M 3.73B 289M 282M 11.8B
Net Debt - -
Logo Embecta Corp.
Embecta Corp. is a global medical device company. It provides solutions to improve the health and well-being of people living with diabetes. Its portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through channels, including retail, hospitals and pharmacies. It is also a manufacturer of medical devices and drug delivery technologies.
Employees
1,850
Date Price Change Volume
26-09-11 US$4.940 +1.02% 1,133,390
26-09-10 US$4.890 -4.49% 1,375,212
26-09-09 US$5.120 -7.75% 1,528,205
26-09-08 US$5.550 -4.31% 1,361,579
26-09-04 US$5.800 +1.93% 1,001,178
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
4.940USD
Average target price
4.000USD
Spread / Average Target
-19.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMBC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!